IBIO ▼ -1.1% - iBio, Inc.
$IBIO - iBio Highlights Data from a Non-human Primate Study Supporting IBIO-610’s Potential to Preserve Muscle in Combination with GLP-1 Therapy
13-OCT-2026 07:00 AM ET
Share this post
More filings for $IBIO
IBIO ▼ -0.8% - iBio, Inc.Sep 1, 2026IBIO ▲ +2.1% - iBio, Inc.Aug 28, 2026IBIO - iBio, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 15, 2026IBIO - iBio, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026IBIO - iBio, Inc. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026
View full $IBIO filing history →💬 Comments
Loading comments…
Leave a comment